Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Palecomic
    Member
    • Aug 2010
    • 34

    #1

    PCR product normalization

    We're multiplexing quite variable PCR products from environmental samples in single runs on a 454 Junior. Increasing the multiplex level to the most cost effective (we've got lots of samples!) means making sure you get a similar number of reads for each sample. As it's a Junior and we get only 70,000 reads a run when we're cooking, at the higher numbers of samples it can mean getting no reads (after QC and removal of bad reads) for particular samples in the run.

    Initially I was carefully quantifying with PicoGreen and Invitrogen's Quant-it kits and diluting pools of products based on that. Typically amplicons range in abundance by 3 orders of magnitude, and (unintuitively) the low abundance amplicons tend to have many more reads. I wonder whether the kit is underestimating the amount of product (standard curves are linear with reproducibly good R^2 values)? The amplicons that are most abundant, and therefore diluted more are consistently the least represented in reads.

    My next approach has been to quantify all amplicons, dilute to a similar order of magnitude, re-quantify and dilute them all to the correct molecules/µl input. Which still shows significant variability and is mind-numbingly tedious (and therefore error-prone!).

    What other strategies do people use for normalization?

    Does anyone have experience of the SequalPrep plates from Invitrogen? Do they work as they say? I would expect them not to be good with low abundance products (for some samples I pool several PCR reactions in order to get sufficient product to sequence, but I could pre-concentrate with an Ampure Xp purification, prior to using the SequalPrep plate?).

    Thanks for your help

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:52 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...